Scenario of North America Artificial Intelligence in Drug Discovery Market Outlook: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Artificial intelligence for drug discovery is a technology that utilizes and dissimilar algorithms that value add in decision-making procedures for drug discovery. The growing cases of rare diseases and requirement for personalized drug are the foremost factor propelling the growth of the North America Artificial intelligence for Drug Discovery marker. According to the report analysis, ‘North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity’ states that Atomwise, Inc., BenevolentAI, Berg LLC, Bioage, BIOAGE, Cloud Pharmaceuticals, Inc., Cyclica, Deep Genomics, Envisagenics, Exscientia, Google, IBM Corporation, Insilico Medicine, Microsoft Corporation, Numedii, Inc., Numerate, NVIDIA Corporation, Owkin, Inc., Twoxar, Incorporated, Verge Genomics, Xtalpi, Inc. and several others are the great corporate which recently operating more effectively in the North America Artificial Intelligence (AI) in drug delivery for leading the highest market growth and dominating the handsome value of market share around the region while establishing the several research and development programs, analyzing the strategies and policies of the government as well as corporate, implementing the policies of enlargements and profit making, employing the young and active players, delivering the better consumer satisfaction, spreading the awareness connected to the applications of such, improving the qualitative and quantitative measures of such, and increasing the applications and specifications of such. In addition, the growth of the artificial intelligence in drug discovery market is principally driven by factors such as the increasing number of cross-industry collaborations and partnerships, the growing need to control drug discovery & development costs and decrease the entire time taken in this process, the growing adoption of cloud-based applications & services, and the approaching patent expiry of blockbuster drugs. Furthermore, reliant on the application, the artificial intelligence in the drug discovery market is classified into neurodegenerative diseases, immuno-oncology, cardiovascular disease, metabolic diseases, and many other applications. Neurodegenerative diseases form the fastest-growing application sector, with a highest CAGR throughout the forecast duration. The ability of AI to discover drugs for composite conditions and the emphasis of market players on delivering the AI-based platforms for neurological diseases are accountable for the fast growth of this application sector. Moreover, it is predicted that North America was the largest and the fastest-growing regional market for artificial intelligence in drug discovery. North America, which entails the US, Canada, and Mexico, forms the greatest market for AI in drug discovery. These regions have been early adopters of AI technology in drug discovery and improvement. In the North American market, the US is a foremost contributor. Also, protuberant AI technology providers, such as IBM, Google, Microsoft, NVIDIA, and Intel, are headquartered in the US; their strong existence is a foremost contributor to market growth. Other drivers comprise the well-established pharmaceutical industry, great focus on R&D & substantial investment, and the existence of globally leading pharmaceutical corporate. These are some of the foremost factors accountable for the large share and great growth rate of this market. Therefore, in the near years, it is predicted that the market of Artificial intelligence in drug discovery will increase around the region as well as globe over the forthcoming years. For More Information, click on the link below:- North America Artificial Intelligence in Drug Discovery Market Related Report:- Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications ankur@kenresearch.com +91-9015378249 Tags: Artificial Intelligence in Drug Discovery Industry in North America, Artificial Intelligence in Drug Discovery Market in North America, Atomwise Inc. Artificial Intelligence in Drug Discovery Market, BenevolentAI Artificial Intelligence in Drug Discovery Market, Berg LLC Artificial Intelligence in Drug Discovery Market, Bioage Artificial Intelligence in Drug Discovery Market, Cloud Pharmaceuticals Inc. Artificial Intelligence in Drug Discovery Market, Cyclica Artificial Intelligence in Drug Discovery Market, Deep Genomics Artificial Intelligence in Drug Discovery Market, Envisagenics Artificial Intelligence in Drug Discovery Market, Exscientia Artificial Intelligence in Drug Discovery Market, Global Artificial Intelligence in Drug Discovery Industry, Global Artificial Intelligence in Drug Discovery Market, Google Artificial Intelligence in Drug Discovery Market, IBM Corporation Artificial Intelligence in Drug Discovery Market, Insilico Medicine Artificial Intelligence in Drug Discovery Market, Microsoft Corporation Artificial Intelligence in Drug Discovery Market, North America AI in Drug Discovery Industry, North America AI in Drug Discovery Market, North America Artificial Intelligence in Drug Discovery Industry, North America Artificial Intelligence in Drug Discovery Industry Research, North America Artificial Intelligence in Drug Discovery Industry Research Report, North America Artificial Intelligence in Drug Discovery Market, North America Artificial Intelligence in Drug Discovery Market Analysis, North America Artificial Intelligence in Drug Discovery Market Forecast, North America Artificial Intelligence in Drug Discovery Market Future Outlook, North America Artificial Intelligence in Drug Discovery Market Growth, North America Artificial Intelligence in Drug Discovery Market Key Players, North America Artificial Intelligence in Drug Discovery Market Research, North America Artificial Intelligence in Drug Discovery Market Research Report, North America Artificial Intelligence in Drug Discovery Market Revenue, North America Artificial Intelligence in Drug Discovery Market Scope, North America Artificial Intelligence in Drug Discovery Market Share, North America Artificial Intelligence in Drug Discovery Market Size, North America Artificial Intelligence in Drug Discovery Market Trends, Numedii Inc. Artificial Intelligence in Drug Discovery Market, Numerate Artificial Intelligence in Drug Discovery Market, NVIDIA Corporation Artificial Intelligence in Drug Discovery Market, Owkin Inc. Artificial Intelligence in Drug Discovery Market, Twoxar Incorporated Artificial Intelligence in Drug Discovery Market, Verge Genomics Artificial Intelligence in Drug Discovery Market, Xtalpi Inc. Artificial Intelligence in Drug Discovery Market